Literature DB >> 12654266

NMR structure of Citrobacter freundii AmpD, comparison with bacteriophage T7 lysozyme and homology with PGRP domains.

Edvards Liepinsh1, Catherine Généreux, Dominique Dehareng, Bernard Joris, Gottfried Otting.   

Abstract

AmpD is a bacterial amidase involved in the recycling of cell-wall fragments in Gram-negative bacteria. Inactivation of AmpD leads to derepression of beta-lactamase expression, presenting a major pathway for the acquisition of constitutive antibiotic resistance. Here, we report the NMR structure of AmpD from Citrobacter freundii (PDB accession code 1J3G). A deep substrate-binding pocket explains the observed specificity for low molecular mass substrates. The fold is related to that of bacteriophage T7 lysozyme. Both proteins bind zinc at a conserved site and require zinc for amidase activity, although the enzymatic mechanism seems to differ in detail. The structure-based sequence alignment identifies conserved features that are also conserved in the eukaryotic peptidoglycan recognition protein (PGRP) domains, including the zinc-coordination site in several of them. PGRP domains thus belong to the same fold family and, where zinc-binding residues are conserved, may have amidase activity. This hypothesis is supported by the observation that human serum N-acetylmuramyl-L-alanine amidase seems to be identical with a soluble form of human PGRP-L. Copyright 2003 Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654266     DOI: 10.1016/s0022-2836(03)00185-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.

Authors:  Amber J Schmidtke; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Substrate-induced inactivation of the Escherichia coli AmiD N-acetylmuramoyl-L-alanine amidase highlights a new strategy to inhibit this class of enzyme.

Authors:  Anne Pennartz; Catherine Généreux; Claudine Parquet; Dominique Mengin-Lecreulx; Bernard Joris
Journal:  Antimicrob Agents Chemother       Date:  2009-02-23       Impact factor: 5.191

3.  Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem.

Authors:  Yi-Tzu Lee; Te-Li Chen; Leung-Kei Siu; Chien-Pei Chen; Chang-Phone Fung
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

4.  Crystal structures of bacterial peptidoglycan amidase AmpD and an unprecedented activation mechanism.

Authors:  Cesar Carrasco-López; Alzoray Rojas-Altuve; Weilie Zhang; Dusan Hesek; Mijoon Lee; Sophie Barbe; Isabelle André; Pilar Ferrer; Noella Silva-Martin; German R Castro; Martín Martínez-Ripoll; Shahriar Mobashery; Juan A Hermoso
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

Review 5.  Bacterial cell-wall recycling.

Authors:  Jarrod W Johnson; Jed F Fisher; Shahriar Mobashery
Journal:  Ann N Y Acad Sci       Date:  2012-11-16       Impact factor: 5.691

Review 6.  Peptidoglycan hydrolases of Escherichia coli.

Authors:  Jean van Heijenoort
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

7.  Bacterial genes in the aphid genome: absence of functional gene transfer from Buchnera to its host.

Authors:  Naruo Nikoh; John P McCutcheon; Toshiaki Kudo; Shin-ya Miyagishima; Nancy A Moran; Atsushi Nakabachi
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

8.  Mutational analysis of the catalytic centre of the Citrobacter freundii AmpD N-acetylmuramyl-L-alanine amidase.

Authors:  Catherine Généreux; Dominique Dehareng; Bart Devreese; Jozef Van Beeumen; Jean-Marie Frère; Bernard Joris
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

9.  Elucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic Data.

Authors:  Veronica N Kos; Robert E McLaughlin; Humphrey A Gardner
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

Review 10.  How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan).

Authors:  James T Park; Tsuyoshi Uehara
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.